Post kala-azar dermal leishmaniasis: an unresolved mystery

被引：98
作者：
Mukhopadhyay, Debanjan [1 ]
Dalton, Jane E. [2 ,3 ]
Kaye, Paul M. [2 ,3 ]
Chatterjee, Mitali [1 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Pharmacol, Kolkata 700020, India
[2] Univ York, Hull York Med Sch, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England
[3] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England
来源：
TRENDS IN PARASITOLOGY | 2014年 / 30卷 / 02期
基金：
英国医学研究理事会;
关键词：
ULTRAVIOLET-B RADIATION; SLC11A1 FORMERLY NRAMP1; NECROSIS-FACTOR-ALPHA; VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; GENETIC SUSCEPTIBILITY; AMPHOTERICIN-B; VITAMIN-D; INFECTIOUS-DISEASE; LANGERHANS CELLS;
D O I：
10.1016/j.pt.2013.12.004
中图分类号：
R38 [医学寄生虫学]; Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ; 100103 ;
摘要：
Post kala-azar dermal leishmaniasis (PKDL), a cutaneous sequela of visceral leishmaniasis (VI), develops in some patients alongside but more commonly after apparent cure from VL. In view of the pivotal role of PKDL patients in the transmission of VL, here we review clinical, epidemiological, parasitological, and immunological perspectives of this disease, focusing on five hypotheses to explain the development of PKDL: (i) the role of antimonial drugs; (ii) UV-induced skin damage; (iii) reinfection; (iv) organ specific failure of memory T cell responses; and (v) genetic susceptibility of the host. This review will enable researchers and clinicians to explore the unresolved mystery of PKDL and provide a framework for future application of 'omic' approaches for the control and eventual elimination of VI.
引用
收藏
页码：65 / 74
页数：10
相关论文
共 50 条
  • [31] Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis
    Mukhopadhyay, Debanjan
    Das, Nilay Kanti
    De Sarkar, Sritama
    Manna, Alak
    Ganguly, Dwijendra Nath
    Barbhuiya, Joyashree Nath
    Maitra, Arup K.
    Hazra, Avijit
    Chatterjee, Mitali
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2012, 106 (11) : 668 - 676
  • [32] Identification of Clinical Immunological Determinants in Asymptomatic VL and Post Kala-azar Dermal Leishmaniasis Patients
    Singh, Ashish Kumar
    Das, Vidya Nand Rabi
    Amit, Ajay
    Dikhit, Manas R.
    Mahantesh, Vijaya
    Kumar, Akhilesh
    Pandey, Raj Kishore
    Naryan, Shyam
    Singh, Bipin K.
    Pandey, Krishna
    Verma, Neena
    Das, Pradeep
    Bimal, Sanjiva
    IRANIAN JOURNAL OF PARASITOLOGY, 2018, 13 (04) : 541 - 548
  • [33] Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis
    Mukherjee, Shibabrata
    Mukhopadhyay, Debanjan
    Braun, Claudia
    Barbhuiya, Joyashree N.
    Das, Nilay K.
    Chatterjee, Uttara
    von Stebut, Esther
    Chatterjee, Mitali
    EXPERIMENTAL DERMATOLOGY, 2015, 24 (03) : 232 - 234
  • [34] Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasis
    Singh, Ashish K.
    Das, Vidya N. R.
    Amit, Ajay
    Dikhit, Manas R.
    Mahantesh, Vijaya
    Singh, Shubhankar K.
    Naryan, Shyam
    Pandey, Krishna
    Das, Pradeep
    Verma, Neena
    Bimal, Sanjiva
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (09) : 7406 - 7418
  • [35] Immune recovery-related patterns of post kala-azar dermal and ocular leishmaniasis in people living with HIV
    Rousset, Stella
    Zenou, Mathilde
    Saunier, Aurelie
    Varenne, Fanny
    Soler, Vincent
    Tournier, Emilie
    Legrand, Lea
    Lachaud, Laurence
    Buffet, Pierre
    Berry, Antoine
    Delobel, Pierre
    Martin-Blondel, Guillaume
    AIDS, 2022, 36 (13) : 1819 - 1827
  • [36] Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis
    Salotra, Poonam
    Duncan, Robert C.
    Singh, Ruchi
    Raju, B. V. Subba
    Sreenivas, Gannavaram
    Nakhasi, Hira L.
    MICROBES AND INFECTION, 2006, 8 (03) : 637 - 644
  • [37] Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India
    Ramesh, V.
    Singh, Ruchi
    Avishek, Kumar
    Verma, Aditya
    Deep, Deepak Kumar
    Verma, Sandeep
    Salotra, Poonam
    PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (10):
  • [38] The immunology of post-kala-azar dermal leishmaniasis (PKDL)
    Eduard E. Zijlstra
    Parasites & Vectors, 9
  • [39] Clinical and Immunological Aspects of Post-Kala-Azar Dermal Leishmaniasis in Bangladesh
    Islam, Shamim
    Kenah, Eben
    Bhuiyan, Mohammed Ashraful Alam
    Rahman, Kazi Mizanur
    Goodhew, Brook
    Ghalib, Chowdhury Mohammad
    Zahid, M. M.
    Ozaki, Masayo
    Rahman, M. W.
    Haque, Rashidul
    Luby, Stephen P.
    Maguire, James H.
    Martin, Diana
    Bern, Caryn
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (02) : 345 - 353
  • [40] Visceral leishmaniasis (Kala-azar) without Splenomegaly
    Gopal Shankar Sahni
    Indian Pediatrics, 2012, 49 : 590 - 591
12345